StockData
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. (BBOT) dividend history

BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.14−0.21 (-8.94%)

Close on Nov 13, 2026Market cap $171.57MP/E –Yield –

Dividends

BridgeBio Oncology Therapeutics has not reported a dividend

No dividend per share appears in BridgeBio Oncology Therapeutics's annual filings since fiscal 2022.

See a number that looks wrong?